Comment on: 'An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials'
- PMID: 29610520
- PMCID: PMC6043489
- DOI: 10.1038/s41433-018-0083-6
Comment on: 'An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials'
Conflict of interest statement
The authors declare that they have no conflict of interest.
Comment on
-
An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials.Eye (Lond). 2018 Jan;32(1):74-80. doi: 10.1038/eye.2017.150. Epub 2017 Jul 28. Eye (Lond). 2018. PMID: 28752837 Free PMC article. Clinical Trial.
References
-
- Fleck BW, Williams C, Juszczak E, Cocker K, Stenson BJ, Darlow BA, Dai S, Gole GA, Quinn GE, Wallace DK, Ells A, Carden S, Butler L, Clark D, Elder J, Wilson C, Biswas S, Shafiq A, King A, Brocklehurst P, Fielder AR, for the BOOST II Retinal Image Digital Analysis (RIDA) Group. An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials. Eye. 2018;32:74–80. doi: 10.1038/eye.2017.150. - DOI - PMC - PubMed
-
- International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
